Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 23
2005 34
2006 36
2007 47
2008 47
2009 53
2010 46
2011 62
2012 65
2013 59
2014 49
2015 40
2016 43
2017 56
2018 57
2019 44
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

702 results
Results by year
Filters applied: . Clear all
Page 1
Drug safety evaluation of aripiprazole in bipolar disorder.
Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A. Cuomo A, et al. Expert Opin Drug Saf. 2019 Jun;18(6):455-463. doi: 10.1080/14740338.2019.1617847. Epub 2019 May 17. Expert Opin Drug Saf. 2019. PMID: 31072228 Review.
This review focuses on the overall tolerability and safety profile of aripiprazole when used for its bipolar disorder indications, which include acute treatment of manic and mixed episodes and maintenance treatment of bipolar I disorder for the oral formulati …
This review focuses on the overall tolerability and safety profile of aripiprazole when used for its bipolar disorder indicati …
Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.
Li DJ, Tseng PT, Stubbs B, Chu CS, Chang HY, Vieta E, Fornaro M, Carvalho AF, Solmi M, Veronese N, Chen TY, Chen YW, Lin PY, Chow PC. Li DJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):289-301. doi: 10.1016/j.pnpbp.2017.06.023. Epub 2017 Jun 23. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 28651936 Review.
Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehensive meta-analysis to investigate the efficacy and safety profile of aripiprazole in treating BD. ...Aripiprazole was associa …
Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehe …
Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.
Hebbrecht K, Morrens M, Neels H, Roosens L, Sabbe BGC. Hebbrecht K, et al. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):999-1005. doi: 10.1080/17425255.2018.1515911. Epub 2018 Sep 7. Expert Opin Drug Metab Toxicol. 2018. PMID: 30141352 Review.
Aripiprazole once-monthly long-acting injectable (AOM LAI) is a recently US Food and Drug Administration-approved treatment option for maintenance therapy that could be of great value. Areas covered: This paper reviews the pharmacokinetic, efficacy and safety data for AOM
Aripiprazole once-monthly long-acting injectable (AOM LAI) is a recently US Food and Drug Administration-approved treatment option fo
The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review.
Muneer A. Muneer A. Cureus. 2016 Apr 7;8(4):e562. doi: 10.7759/cureus.562. Cureus. 2016. PMID: 27190727 Free PMC article. Review.
Aripiprazole is a novel antipsychotic initially approved for the treatment of schizophrenia but soon found to be effective in bipolar disorder. ...The current review summarizes the data from controlled trials regarding the efficacy and safety of aripiprazole
Aripiprazole is a novel antipsychotic initially approved for the treatment of schizophrenia but soon found to be effective in bipo
Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report.
Ballester-Gracia I, Pérez-Almarcha M, Galvez-Llompart A, Hernandez-Viadel M. Ballester-Gracia I, et al. BMC Pharmacol Toxicol. 2019 Aug 28;20(1):52. doi: 10.1186/s40360-019-0330-x. BMC Pharmacol Toxicol. 2019. PMID: 31462311 Free PMC article. Review.
We present a clinical case of aripiprazole LAI use in pregnancy. CASE PRESENTATION: A 43-year-old woman diagnosed with bipolar disorder, with several relapses due to treatment interruption while trying to conceive. Finally, aripiprazole LAI treatment was plan …
We present a clinical case of aripiprazole LAI use in pregnancy. CASE PRESENTATION: A 43-year-old woman diagnosed with bipolar
Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults.
Aggarwal A, Schrimpf L, Lauriello J. Aggarwal A, et al. Clin Schizophr Relat Psychoses. 2018 Jan;11(4):221-223. doi: 10.3371/CSRP.AGSC.010318. Clin Schizophr Relat Psychoses. 2018. PMID: 29341822 Review.
Bipolar I disorder is a serious and disabling psychiatric illness. It is associated with a significant reduction in quality of life and an increased risk for suicide. ...In this paper we discuss the available data for safety and efficacy of aripiprazole long-acting
Bipolar I disorder is a serious and disabling psychiatric illness. It is associated with a significant reduction in quality of life a
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.
Rapinesi C, Kotzalidis GD, Mazzarini L, Brugnoli R, Ferracuti S, De Filippis S, Cuomo I, Giordano G, Del Casale A, Angeletti G, Sani G, Girardi P. Rapinesi C, et al. Clin Drug Investig. 2019 Aug;39(8):713-735. doi: 10.1007/s40261-019-00801-9. Clin Drug Investig. 2019. PMID: 31152368
OBJECTIVE: To systematically review the effects of the two formulations, Monohydrate and Lauroxil, of Aripiprazole LAI in patients with schizophrenia and bipolar disorder during an acute episode or during maintenance treatment. ...RESULTS: We included 28 papers deal …
OBJECTIVE: To systematically review the effects of the two formulations, Monohydrate and Lauroxil, of Aripiprazole LAI in patients wi …
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice.
Cuomo A, Goracci A, Fagiolini A. Cuomo A, et al. J Affect Disord. 2018 Mar 1;228:229-237. doi: 10.1016/j.jad.2017.12.021. Epub 2017 Dec 14. J Affect Disord. 2018. PMID: 29275156 Review.
BACKGROUND: Aripiprazole is used relatively frequently in women with bipolar disorder or schizophrenia in childbearing years, owing to its efficacy and relatively favorable side effect profile. ...In many cases, the potential benefits of aripiprazole for pati …
BACKGROUND: Aripiprazole is used relatively frequently in women with bipolar disorder or schizophrenia in childbearing years, …
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.
Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, Salzman PM, McQuade RD, Nyilas M, Carson WH. Calabrese JR, et al. J Clin Psychiatry. 2017 Mar;78(3):324-331. doi: 10.4088/JCP.16m11201. J Clin Psychiatry. 2017. PMID: 28146613 Free article. Clinical Trial.
OBJECTIVE: To evaluate efficacy, safety, and tolerability of long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) as maintenance treatment for bipolar I disorder (BP-I). METHODS: In a double-blind, placebo-controlled, 52-week randomized wi …
OBJECTIVE: To evaluate efficacy, safety, and tolerability of long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (A …
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.
Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry PP, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH. Calabrese JR, et al. J Affect Disord. 2018 Dec 1;241:425-432. doi: 10.1016/j.jad.2018.06.043. Epub 2018 Jul 6. J Affect Disord. 2018. PMID: 30145513 Free article. Clinical Trial.
BACKGROUND: Aripiprazole once-monthly 400 mg (AOM 400), an atypical long-acting injectable antipsychotic, has demonstrated efficacy and safety in maintenance treatment of bipolar I disorder (BP-I). We further assess safety and tolerability and characterize adverse e …
BACKGROUND: Aripiprazole once-monthly 400 mg (AOM 400), an atypical long-acting injectable antipsychotic, has demonstrated efficacy a …
702 results
Jump to page
Feedback